Ambee Pharmaceuticals (DHA:AMBEEPHA) EBIT per Share : BDT (TTM As of . 20)

View and export this data going back to 2004. Start your Free Trial

What is Ambee Pharmaceuticals EBIT per Share?

Ambee Pharmaceuticals's EBIT per Share for the six months ended in . 20 was BDT0.00. Ambee Pharmaceuticals does not have enough years/quarters to calculate its EBIT per Share for the trailing twelve months (TTM) ended in . 20.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Ambee Pharmaceuticals's EBIT per Share or its related term are showing as below:

DHA:AMBEEPHA's 3-Year EBIT Growth Rate is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 7.7
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Ambee Pharmaceuticals's EBIT for the six months ended in . 20 was BDT0.00 Mil.

Ambee Pharmaceuticals EBIT per Share Historical Data

The historical data trend for Ambee Pharmaceuticals's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ambee Pharmaceuticals EBIT per Share Chart

Ambee Pharmaceuticals Annual Data

Trend

EBIT per Share

Ambee Pharmaceuticals Semi-Annual Data

EBIT per Share

Ambee Pharmaceuticals EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Ambee Pharmaceuticals's EBIT per Share for the fiscal year that ended in . 20 is calculated as

	EBIT per Share		(A: . 20 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=		/	0
=	N/A

Ambee Pharmaceuticals's EBIT per Share for the quarter that ended in . 20 is calculated as

	EBIT per Share		(Q: . 20 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=		/	0
=	N/A

Ambee Pharmaceuticals (DHA:AMBEEPHA) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Ambee Pharmaceuticals EBIT per Share Related Terms

Thank you for viewing the detailed overview of Ambee Pharmaceuticals's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Ambee Pharmaceuticals (DHA:AMBEEPHA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ambee Pharmaceuticals Plc (DHA:AMBEEPHA) » Definitions » EBIT per Share

Traded in Other Exchanges

N/A

Address

184/1 Tejgaon Industrial Area, Dhaka, BGD, 1208

Website

https://www.ambeepharma.com

Ambee Pharmaceuticals Plc formerly Ambee Pharmaceuticals Ltd manufactures a wide range of pharmaceutical products in Bangladesh. It is engaged in the business of manufacturing drugs and medicine and sales. Its products are sold in the form of tablets, capsules, liquids, gels, and injectables.

Ambee Pharmaceuticals (DHA:AMBEEPHA) Headlines

No Headlines